Is an ounce of prevention worth a pound of cure? Comparing demand for public prevention and treatment policies

Medical Decision Making : an International Journal of the Society for Medical Decision Making
Ryan BosworthJ R DeShazo

Abstract

Public policy can affect the allocation of resources between programs designed to prevent illnesses or injuries and programs designed to treat those who are already sick or injured. Information about preferences for treatment and prevention policies can help policy makers more effectively allocate public health resources among alternative uses. Our objective is to assess preferences for publicly funded health policies designed to prevent or treat major health threats. We use national surveys that employ discrete choice experiment formats. The surveys allow respondents to make trade-offs between policies designed to prevent or treat most major health threats. The surveys were administered to a nationally representative sample of over 3000 respondents. We estimate a random utility model of preferences for treatment and prevention policies and explore sources of systematic heterogeneity in preferences. We estimate marginal utility associated with avoided deaths to be about twice as high for prevention policies as for treatment policies and find statistically significant heterogeneity with respect to disease type, the group targeted by the policy, and respondent characteristics. Preferences for public health policies vary markedly ...Continue Reading

References

Jul 1, 1996·Medical Decision Making : an International Journal of the Society for Medical Decision Making·B KartmanM Johannesson
Jun 1, 1997·Scandinavian Journal of Social Medicine·L A LindholmM E Stenbeck
Aug 1, 1997·Risk Analysis : an Official Publication of the Society for Risk Analysis·J A Ramsberg, L Sjöberg
Nov 14, 1997·JAMA : the Journal of the American Medical Association·J D GrahamM C Weinstein
Apr 16, 1998·Health Economics·N Zethraeus
Nov 3, 1997·Journal of Health Economics·R M O'Conor, G C Blomquist
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Phaedra S CorsoSue J Goldie
May 20, 2003·Social Science & Medicine·Edward R MoreyAnne Mills
Jun 18, 2003·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Eve WittenbergJohn D Graham
Nov 5, 2005·Risk Analysis : an Official Publication of the Society for Risk Analysis·Anna Alberini

❮ Previous
Next ❯

Citations

Aug 16, 2011·Risk Analysis : an Official Publication of the Society for Risk Analysis·Lisa A Robinson, James K Hammitt
Oct 1, 2011·Risk Analysis : an Official Publication of the Society for Risk Analysis·Henrik LindhjemVincent Biausque
Mar 17, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen LuytenPhilippe Beutels
Apr 10, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Donald A Redelmeier
Apr 10, 2014·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Jennifer A WhittyPaul A Scuffham
Jan 13, 2018·Pharmacogenomics·Dyfrig A Hughes, Catrin O Plumpton
Nov 23, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Hannah ChristensenRaymond Farkouh
Apr 29, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Don Husereau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.